-
Revenue: Full Year 2023 GAAP Revenue increased to $882 million, up 2.4% from 2022.
-
Net Income: Full Year GAAP Net Income reported at $73 million, with a slight decrease from the previous year.
-
Earnings Per Share: GAAP Diluted EPS for 2023 stood at $2.02, with Adjusted EPS at $3.02.
-
Adjusted EBITDA: Reached $196 million for the full year, showing robust profitability.
-
Cash Flow: Operating cash flow for the full year 2023 was $120.1 million, a significant increase from 2022.
-
Debt and Cash: Ended the year with approximately $354.4 million in total debt and $105.1 million in total cash.
-
Guidance: For 2024, Novanta expects GAAP revenue of approximately $975 million to $1 billion and Adjusted EBITDA between $215 million to $225 million.
On February 28, 2024, Novanta Inc (NASDAQ:NOVT), a leading provider of core technology solutions for medical and advanced industrial equipment manufacturers, announced its financial results for the fourth quarter and full year 2023. The company released its 8-K filing, detailing a year of growth despite a challenging market environment.
Novanta operates through three segments: photonics, vision, and precision motion. The photonics segment offers products like carbon dioxide lasers and laser scanning, while the vision segment provides medical-grade technologies and contributes the majority of revenue. The precision motion segment delivers optical encoders and motion control technology. The company has a strong presence in the United States and Europe, which are its primary revenue-generating regions.
Performance and Challenges
For the fourth quarter of 2023, Novanta reported a slight decrease in GAAP revenue to $211.6 million, a 3.1% drop from the fourth quarter of 2022. The full year, however, saw an increase in GAAP revenue to $881.7 million, marking a 2.4% rise from the previous year. The company's acquisition activities contributed an increase in revenue of $8.1 million, or 0.9%, and changes in foreign currency exchange rates had a favorable impact of $1.3 million, or 0.2%, in 2023.
Despite the revenue growth, Novanta faced a decrease in GAAP net income, which was $72.9 million for the full year 2023, slightly down from $74.1 million in 2022. GAAP diluted EPS also saw a marginal decrease to $2.02 for the full year 2023, compared to $2.06 for 2022. Adjusted EBITDA, however, increased to $196.2 million for the full year 2023, up from $184.1 million for 2022, reflecting the company's ability to maintain profitability amidst market fluctuations.